1 / 18

TOC - Middle East Molecular Diagnostics Market

The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the forecast period 2021-2031.

bisreports
Download Presentation

TOC - Middle East Molecular Diagnostics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Middle East Molecular Diagnostics Market- Country Analysis Table of Content MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET Focus on Product, Testing Location, Technology, Application, End User, and Country Data Analysis and Forecast: 2021-2031 May 2022 All rights reserved at BIS Research Inc. 1

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. All rights reserved at BIS Research Inc. 2

  3. Table of Content Executive Summary ........................................................................ 17 Research Methodology ................................................................... 23 Scope of the Study .......................................................................... 28 1 Middle East Molecular Diagnostics Market ................................ 30 1.1 Product Definition ............................................................................................ 30 1.1.1Inclusion and Exclusion ............................................................................. 30 1.2 Market Overview .............................................................................................. 31 1.3 Historical Perspective ..................................................................................... 32 1.4 Significant Technologies ................................................................................ 33 1.5 Classification of Molecular Diagnostics ........................................................ 34 1.6 Future Potential ............................................................................................... 36 Industry Insights ....................................................................... 37 2 2.1 Patent Analysis ................................................................................................ 38 2.1.1Patent Filing Trend ...................................................................................... 38 2.2 Legal Requirements ........................................................................................ 38 2.2.1Legal Requirements and Framework in the U.S. ...................................... 38 2.2.2U.S. FDA Regulations .................................................................................. 39 Competitive Landscape ............................................................ 40 3 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET 3.1 Competitive Landscape .................................................................................. 41 3.1.1Acquisitions ................................................................................................. 41 3.1.2Synergistic Activities .................................................................................. 42 3.1.3Product Launches and Upgradations ........................................................ 43 3.1.4Business Expansion ................................................................................... 44 Market Dynamics ...................................................................... 45 4 4.1 Market Dynamics ............................................................................................. 46 4.1.1Impact Analysis ........................................................................................... 46 4.1.2Market Drivers ............................................................................................. 47 All rights reserved at BIS Research Inc. 3

  4. 4.1.2.1 Increasing Prevalence of Infectious Diseases and Various Types of Cancer in the Middle East ............................................................................................. 47 4.1.2.2 Increase in Awareness and Acceptance of Personalized Medicines in the Middle East ...................................................................................................... 49 4.1.2.3 Significant External Funding for Executing Research and Development Exercises ......................................................................................................... 49 4.1.3Market Restraints ........................................................................................ 50 4.1.3.1 Uncertain Reimbursement Scenario ................................................................. 50 4.1.3.2 Lack of High-Complexity Testing Centers in the Middle East ............................ 50 4.1.4Market Opportunities .................................................................................. 51 4.1.4.1 Massive Scope for Adoption of Molecular Diagnostics ..................................... 51 4.1.4.2 Rise of Next-Generation Ultrasensitive Molecular Diagnostics ......................... 51 4.1.4.3 Novel Revenue Streams .................................................................................. 52 4.2 COVID-19 Impact on Middle East Molecular Diagnostics Market ................ 53 4.2.1Impact on Market Size ................................................................................. 54 4.2.2Impact on Molecular Diagnostic Practices ................................................ 54 Middle East Molecular Diagnostics Market, by Products, $Million, 2021 - 2031 ................................................................. 55 5 5.1 Overview ........................................................................................................... 56 5.1.1Systems ........................................................................................................ 57 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET 5.1.2Kits and Consumables ................................................................................ 58 5.1.3Software and Other Products ..................................................................... 61 Middle East Molecular Diagnostics Market, by Testing Location, $Million, 2021 - 2031 .................................................. 64 6 6.1 Overview ........................................................................................................... 65 6.1.1Laboratory Testing ...................................................................................... 66 6.1.2Point-of-Care Testing .................................................................................. 67 Middle East Molecular Diagnostics Market, by Technology, $Million, 2021 - 2031 ................................................................. 69 7 7.1 Overview ........................................................................................................... 70 7.1.1Polymerase Chain Reaction (PCR) ............................................................ 71 All rights reserved at BIS Research Inc. 4

  5. 7.1.2Next-Generation Sequencing ..................................................................... 74 7.1.3Isothermal Nucleic Acid Amplification Technology (INAAT) ................... 75 7.1.4Microarray .................................................................................................... 77 7.1.5In-Situ Hybridization (ISH) .......................................................................... 79 7.1.6Immunohistochemistry (IHC) ..................................................................... 80 7.1.7Other Technologies ..................................................................................... 82 Middle East Molecular Diagnostics Market, by Application, $Million, 2021 - 2031 ................................................................. 84 8 8.1 Overview ........................................................................................................... 85 8.1.1Core Molecular Diagnostics ....................................................................... 86 8.1.2Reproductive Genetics ............................................................................... 87 8.1.3Companion Diagnostics (CDx) ................................................................... 88 8.1.4Liquid Biopsy ............................................................................................... 89 8.1.5Other Applications ...................................................................................... 90 Middle East Molecular Diagnostics Market, by End User, $Million, 2021 - 2031 ................................................................. 92 9 9.1 Overview ........................................................................................................... 93 9.1.1Hospitals ...................................................................................................... 94 9.1.2Diagnostic Centers ...................................................................................... 95 9.1.3Out-Patient Clinics/General Practitioners ................................................. 96 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET 9.1.4Research Laboratories ................................................................................ 97 9.1.5Other End Users .......................................................................................... 98 10Middle East molecular diagnostics Market, by Country, $Million, 2020-2031................................................................... 99 10.1Overview ......................................................................................................... 100 10.1.1Kingdom of Saudi Arabia (KSA) ............................................................... 101 10.1.2Israel ........................................................................................................... 103 10.1.3United Arab Emirates (U.A.E.) .................................................................. 104 10.1.4Egypt .......................................................................................................... 105 10.1.5Iran .............................................................................................................. 106 10.1.6Qatar ........................................................................................................... 107 All rights reserved at BIS Research Inc. 5

  6. 10.1.7Rest-of-the-Middle East ............................................................................ 108 11Market - Competitive Benchmarking & Company Profiles ........ 109 11.1Overview ......................................................................................................... 110 11.2Abbott. ............................................................................................................ 111 11.2.1Company Overview ................................................................................... 111 11.2.2Role of Abbott. in the Middle East Molecular Diagnostics Market ........ 111 11.2.3Key Competitors of the Company ............................................................ 111 11.2.4Key Customers of the Company .............................................................. 111 11.2.5Business Strategies .................................................................................. 112 11.2.6Financials ................................................................................................... 113 11.2.7Key Insights about Financial Health of the Company ............................ 115 11.2.8SWOT Analysis .......................................................................................... 116 11.3Agilent Technologies, Inc. ............................................................................ 117 11.3.1Company Overview ................................................................................... 117 11.3.2Role of Agilent Technologies, Inc. in the Middle East Molecular Diagnostics Market .................................................................................... 117 11.3.3Key Competitors of the Company ............................................................ 117 11.3.4Key Customers of the Company .............................................................. 117 11.3.5Business Strategies .................................................................................. 118 11.3.6Corporate Strategies: ................................................................................ 118 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET 11.3.7Financials ................................................................................................... 119 11.3.8Key Insights about Financial of the Company ........................................ 121 11.3.9SWOT Analysis .......................................................................................... 122 11.4bioMérieux SA ................................................................................................ 123 11.4.1Company Overview ................................................................................... 123 11.4.2Role of bioMérieux SA in the Middle East Molecular Diagnostics Market ......................................................................................................... 123 11.4.3Key Competitors of the Company ............................................................ 123 11.4.4Key Customers of the Company .............................................................. 123 11.4.5Business Strategies .................................................................................. 124 All rights reserved at BIS Research Inc. 6

  7. 11.4.6Financials ................................................................................................... 125 11.4.7Key Insights about the Financial Health of the Company ...................... 126 11.4.8SWOT Analysis .......................................................................................... 127 11.5BD. .................................................................................................................. 128 11.5.1Company Overview ................................................................................... 128 11.5.2Role of BD. in the Middle East Molecular Diagnostics Market .............. 128 11.5.3Key Competitors of the Company ............................................................ 128 11.5.4Key Customers of the Company .............................................................. 129 11.5.5Business Strategies .................................................................................. 129 11.5.6Financials ................................................................................................... 130 11.5.7Key Insights about Financial Health of the Company ............................ 132 11.5.8SWOT Analysis .......................................................................................... 133 11.6Babirus Medical Equipment LLC .................................................................. 134 11.6.1Company Overview ................................................................................... 134 11.6.2Role of Babirus Medical Equipment Trading LLC in the Middle East Molecular Diagnostics Market .................................................................. 134 11.6.3Key Competitors of the Company ............................................................ 134 11.6.4Key Customers of the Company .............................................................. 134 11.6.5Business Strategies .................................................................................. 135 11.6.6SWOT Analysis .......................................................................................... 136 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET 11.7Bio-Rad Laboratories, Inc. ............................................................................ 137 11.7.1Company Overview ................................................................................... 137 11.7.2Role of Bio-Rad Laboratories, Inc. in the Middle East Molecular Diagnostics Market .................................................................................... 137 11.7.3Key Competitors of the Company ............................................................ 137 11.7.4Key Customers of the Company .............................................................. 138 11.7.5Business Strategies .................................................................................. 138 11.7.5.1 Corporate Strategies ...................................................................................... 138 11.7.6Financials ................................................................................................... 139 11.7.7Key Insights about Financial Health of the Company ............................ 141 All rights reserved at BIS Research Inc. 7

  8. 11.7.8SWOT Analysis .......................................................................................... 142 11.8Danaher. ......................................................................................................... 143 11.8.1Company Overview ................................................................................... 143 11.8.2Role of Danaher. in the Middle East Molecular Diagnostics Market ..... 143 11.8.3Key Competitors of the Company ............................................................ 143 11.8.4Key Customers of the Company .............................................................. 143 11.8.5Business Strategies .................................................................................. 144 11.8.6Corporate Strategies ................................................................................. 144 11.8.7Financials ................................................................................................... 145 11.8.8Key Insights about Financial Health of the Company ............................ 147 11.8.9SWOT Analysis .......................................................................................... 148 11.9F. Hoffmann-La Roche Ltd. ........................................................................... 149 11.9.1Company Overview ................................................................................... 149 11.9.2Role of F. Hoffmann-La Roche Ltd. in the Middle East Molecular Diagnostics Market .................................................................................... 149 11.9.3Key Competitors of the Company ............................................................ 149 11.9.4Key Customers of the Company .............................................................. 149 11.9.5Business Strategies .................................................................................. 150 11.9.6Corporate Strategies ................................................................................. 150 11.9.7Financials ................................................................................................... 151 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET 11.9.8Key Insights about Financial Health of the Company ............................ 153 11.9.9SWOT Analysis .......................................................................................... 154 11.10Guardant Health ............................................................................................. 155 11.10.1 Company Overview ............................................................................. 155 11.10.2 Role of Guardant Health in the Middle East Molecular Diagnostics Market .................................................................................... 155 11.10.3 Key Competitors of the Company ..................................................... 155 11.10.4 Key Customers of the Company ........................................................ 156 11.10.5 Corporate Strategies ........................................................................... 156 11.10.6 Financials ............................................................................................ 156 All rights reserved at BIS Research Inc. 8

  9. 11.10.7 Key Insights about Financial Health of the Company ...................... 158 1.1.1SWOT Analysis .......................................................................................... 159 11.11Illumina, Inc. ................................................................................................... 160 11.11.1 Company Overview ............................................................................. 160 11.11.2 Role of Illumina, Inc. in the Middle East Molecular Diagnostics Market ......................................................................................................... 160 11.11.3 Key Competitors of the Company ..................................................... 160 11.11.4 Key Customers of the Company ........................................................ 160 11.11.5 Corporate Strategies ........................................................................... 161 11.11.6 Financials ............................................................................................ 162 11.11.7 Key Insights about the Financial Health of the Company ............... 163 11.11.8 SWOT Analysis.................................................................................... 164 11.12QIAGEN N.V. ................................................................................................... 165 11.12.1 Company Overview ............................................................................. 165 11.12.2 Role of QIAGEN N.V. in the Middle East Molecular Diagnostics Market ......................................................................................................... 165 11.12.3 Key Competitors of the Company ..................................................... 166 11.12.4 Key Customers of the Company ........................................................ 166 11.12.5 Corporate Strategies ........................................................................... 166 11.12.6 Key Insights about Financial Health of the Company ...................... 169 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET 11.12.7 SWOT Analysis.................................................................................... 170 11.13Thermo Fisher Scientific Inc. ........................................................................ 171 11.13.1 Company Overview ............................................................................. 171 11.13.2 Role of Thermo Fisher Scientific Inc. in the Middle East Molecular Diagnostics Market .................................................................. 171 11.13.3 Key Competitors of the Company ..................................................... 172 11.13.4 Key Customers of the Company ........................................................ 172 11.13.5 Business Strategies ............................................................................ 172 11.13.6 Financials ............................................................................................ 173 11.13.7 Key Insights about Financial Health of the Company ...................... 174 11.13.8 SWOT Analysis.................................................................................... 175 All rights reserved at BIS Research Inc. 9

  10. List of Figures Figure 1: Middle East Molecular Diagnostics Market-Market Dynamics Figure 2: Share of Key Market Strategies and Developments, January 2017-September 2021 Figure 3: Middle East Molecular Diagnostics Market Snapshot, $Million, 2020-2031 Figure 4: Middle East Molecular Diagnostics Market (by Product), $Million, 2020 Vs. 2031 Figure 5: Middle East Molecular Diagnostics Market (by Technology), $Million, 2020 Vs. 2031 Figure 6: Middle East Molecular Diagnostics Market (by Application), $Million, 2020 Vs. 2031 Figure 7: Middle East Molecular Diagnostics Market (by End User), $Million, 2020 Vs. 2031 Figure 8: Middle East Molecular Diagnostics Market Research Methodology Figure 9: Middle East Molecular Diagnostics Market: Segmentation Figure 10: Role of Diagnostics in Healthcare Figure 11: Evolution of Molecular Diagnostics Figure 12: Classification of Molecular Diagnostics Figure 13: Year-Wise Analysis of Patents Related to Molecular Diagnostics, January 2019-October 2021 Figure 14: Share of Key Developments and Strategies, January 2017-September 2021 Figure 15: Share of Acquisitions (by Company), January 2017-September 2021 Figure 16: Share of Synergistic Activities (by Company), January 2017-September 2021 Figure 17: Share of Product Launches and Upgradations (by Company), January 2017-September 2021 Figure 18: Share of Business Expansion (by Company), July 2017-August 2021 Figure 19: Middle East Molecular Diagnostics Market - Market Dynamics MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET Figure 20: Rate of Cancer Incidence and Death in 2020 Figure 21: Personalized Care for Cancer Patients Figure 22: Impact of COVID-19 on Middle East Molecular Diagnostics Market Figure 23: Share of Middle East Molecular Diagnostics Market (by Product), $Million, 2020 and 2031 Figure 24: Middle East Molecular Diagnostics Market (Systems), $Million, 2020-2031 Figure 25: General Workflow of a Molecular Diagnostic Kit Figure 26: Middle East Molecular Diagnostics Market (Kits and Consumables), $Million, 2020-2031 Figure 27: Aspects of Software Development Figure 28: Middle East Molecular Diagnostics Market (Software and Other Products), $Million, 2020- 2031 Figure 29: Middle East Molecular Diagnostics Market (by Testing Location) All rights reserved at BIS Research Inc. 10

  11. Figure 30: Share of Middle East Molecular Diagnostics Market (by Testing Location), $Million, 2020 and 2031 Figure 31: Middle East Molecular Diagnostics Market (Laboratory Testing), $Million, 2020-2031 Figure 32: Middle East Molecular Diagnostics Market (Point-of-Care Testing), $Million, 2020-2031 Figure 33: Share of Middle East Molecular Diagnostics Market (by Technology), $Million, 2020 and 2031 Figure 34: Middle East Molecular Diagnostics Market (Polymerase Chain Reaction), $Million, 2020-2031 Figure 35: Middle East Molecular Diagnostics Market (Next-Generation Sequencing), $Million, 2020- 2031 Figure 36: Middle East Molecular Diagnostics Market (Isothermal Nucleic Acid Amplification Technology), $Million, 2020-2031 Figure 37: Middle East Molecular Diagnostics Market (Microarray), $Million, 2020-2031 Figure 38: Middle East Molecular Diagnostics Market (ISH), $Million, 2020-2031 Figure 39: Middle East Molecular Diagnostics Market (IHC), $Million, 2020-2031 Figure 40: Middle East Molecular Diagnostics Market (Other Technologies), $Million, 2020-2031 Figure 41: Middle East Molecular Diagnostics Market (by Application), $Million, 2020 and 2031 Figure 42: Middle East Molecular Diagnostics Market (Core Molecular Diagnostics), $Million, 2020-2031 Figure 43: Middle East Molecular Diagnostics Market (Reproductive Genetics), $Million, 2020-2031 Figure 44: Middle East Molecular Diagnostics Market (Companion Diagnostics), $Million, 2020-2031 Figure 45: Middle East Molecular Diagnostics Market (Liquid Biopsy), $Million, 2020-2031 Figure 46: Middle East Molecular Diagnostics Market (Other Applications), $Million, 2020-2031 Figure 47: Share of Middle East Molecular Diagnostics Market (by End User), $Million, 2020 and 2031 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET Figure 48: Middle East Molecular Diagnostics Market (Hospitals), $Million, 2020-2031 Figure 49: Middle East Molecular Diagnostics Market (Diagnostic Centers), $Million, 2020-2031 Figure 50: Middle East Molecular Diagnostics Market (Out-Patient Clinics/General Practitioners), $Million, 2020-2031 Figure 51: Middle East Molecular Diagnostics Market (Research Laboratories), $Million, 2020-2031 Figure 52: Middle East Molecular Diagnostics Market (Other End Users), $Million, 2020-2031 Figure 53: Middle East Molecular Diagnostics Market (by Country), $Million, 2020-2031 Figure 54: Middle East Molecular Diagnostics Market (by Country), 2021 and 2031 Figure 55: Kingdom of Saudi Arabia Diagnostics Market $Million, 2020-2031 Figure 56: Israel Molecular Diagnostics Market, $Million, 2020-2031 Figure 57: U.A.E. Molecular Diagnostics Market, $Million, 2020-2031 Figure 58: Egypt Molecular Diagnostics Market, $Million, 2020-2031 All rights reserved at BIS Research Inc. 11

  12. Figure 59: Iran Molecular Diagnostics Market, $Million, 2020-2031 Figure 60: Qatar Molecular Diagnostics Market, $Million, 2020-2031 Figure 61: Rest-of-the-Middle East Molecular Diagnostics Market, $Million, 2020-2031 Figure 62: Total Number of Companies Profiled Figure 63: Abbott.: Overall Product Portfolio Figure 64: Abbott.: Overall Financials, 2019-2021 Figure 65: Abbott.: Revenue (by Segment), 2019-2021 Figure 66: Abbott.: Revenue (by Region), 2019-2021 Figure 67: Abbott.: R&D Expenditure, 2019-2021 Figure 68: Abbott.: SWOT Analysis Figure 69: Agilent Technologies, Inc.: Overall Product Portfolio Figure 70: Agilent Technologies, Inc.: Overall Financials, 2019-2021 Figure 71: Agilent Technologies, Inc.: Revenue (by Segment), 2019-2021 Figure 72: Agilent Technologies, Inc.: Revenue (by Region), 2019-2021 Figure 73: Agilent Technologies, Inc.: R&D Expenditure, 2019-2021 Figure 74: Agilent Technologies, Inc.: SWOT Analysis Figure 75: bioMérieux SA: Product Portfolio Figure 76: bioMérieux SA: Overall Financials, $Million, 2019-2021 Figure 77: bioMérieux SA: Revenue (by Segment), $Million, 2019-2021 Figure 78: bioMérieux SA: Revenue (by Region), $Million, 2019-2021 Figure 79: bioMérieux SA: R&D Expenditure, $Million, 2019-2021 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET Figure 80: bioMérieux SA: SWOT Analysis Figure 81: BD.: Overall Product Portfolio Figure 82: BD.: Overall Financials, 2019-2021 Figure 83: BD.: Revenue (by Segment), 2019-2021 Figure 84: BD.: Revenue (by Region), 2019-2021 Figure 85: BD.: R&D Expenditure, 2019-2021 Figure 86: BD.: SWOT Analysis Figure 87: Babirus Medical Equipment Trading LLC: Overall Product Portfolio Figure 88: Babirus Medical Equipment Trading LLC: SWOT Analysis Figure 89: Bio-Rad Laboratories, Inc.: Overall Product Portfolio Figure 90: Bio-Rad Laboratories, Inc.: Overall Financials, 2019-2021 Figure 91: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2019-2021 All rights reserved at BIS Research Inc. 12

  13. Figure 92: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2019-2021 Figure 93: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2019-2021 Figure 94: Bio-Rad Laboratories, Inc.: SWOT Analysis Figure 95: Danaher.: Overall Product Portfolio Figure 96: Danaher.: Overall Financials, 2019-2021 Figure 97: Danaher.: Revenue (by Segment), 2019-2021 Figure 98: Danaher.: Revenue (by Region), 2019-2021 Figure 99: Danaher.: R&D Expenditure, 2019-2021 Figure 100: Danaher.: SWOT Analysis Figure 101: F. Hoffmann-La Roche Ltd: Overall Product Portfolio Figure 102: F. Hoffmann-La Roche Ltd: Overall Financials, 2019-2021 Figure 103: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2019-2021 Figure 104: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2019-2021 Figure 105: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2019-2021 Figure 106: F. Hoffmann-La Roche Ltd: SWOT Analysis Figure 107: Guardant Health: Overall Product Portfolio Figure 108: Guardant Health: Overall Financials, 2018-2020 Figure 109: Guardant Health: Revenue (by Segment), 2018-2020 Figure 110: Guardant Health: R&D Expenditure, 2018-2020 Figure 111: Guardant Health: SWOT Analysis Figure 112: Illumina, Inc.: Product Portfolio MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET Figure 113: Illumina, Inc.: Overall Financials, $Million, 2019-2021 Figure 114: Illumina, Inc.: Revenue (by Segment), $Million, 2019-2021 Figure 115: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021 Figure 116: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 117: Illumina, Inc.: SWOT Analysis Figure 118: QIAGEN N.V.: Overall Product Portfolio Figure 119: QIAGEN N.V.: Overall Financials, 2019-2021 Figure 120: QIAGEN N.V.: Revenue (by Segment), 2019-2021 Figure 121: QIAGEN N.V.: Revenue (by Region), 2019-2021 Figure 122: QIAGEN N.V.: R&D Expenditure, 2019-2021 Figure 123: QIAGEN N.V.: SWOT Analysis Figure 124: Thermo Fisher Scientific Inc.: Overall Product Portfolio All rights reserved at BIS Research Inc. 13

  14. Figure 125: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021 Figure 126: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), $Million, 2019-2021 Figure 127: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021 Figure 128: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021 Figure 129: Thermo Fisher Scientific Inc.: SWOT Analysis MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET All rights reserved at BIS Research Inc. 14

  15. List of Tables Table 1: COVID-19 Impact on Middle East Molecular Diagnostics Market MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET All rights reserved at BIS Research Inc. 15

  16. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET Know More All rights reserved at BIS Research Inc. 16

  17. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET All rights reserved at BIS Research Inc. 17

  18. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com All rights reserved at BIS Research Inc. 18

More Related